Healthpeak Properties, Inc. SEC filings DOC

Healthpeak Properties, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Jun 3, 2014. Its latest annual report, Form ARS, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Healthpeak Properties, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 2, 2026 Nov 2, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 4, 2026 Aug 4, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 22, 2026 —
4 Insider transaction Jun 2, 2026 May 29, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
4 Insider transaction May 18, 2026 May 14, 2026
SCHEDULE 13G Ownership over 5% (passive) May 14, 2026 —
4 Insider transaction May 13, 2026 May 12, 2026
SCHEDULE 13G Ownership over 5% (passive) May 13, 2026 —
144 Notice of proposed sale May 12, 2026 —
4 Insider transaction May 7, 2026 May 6, 2026
4 Insider transaction May 7, 2026 May 6, 2026
4 Insider transaction May 7, 2026 May 6, 2026
4 Insider transaction May 7, 2026 May 6, 2026
4 Insider transaction May 7, 2026 May 6, 2026
4 Insider transaction May 7, 2026 May 6, 2026
4 Insider transaction May 7, 2026 May 6, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 5, 2026 May 5, 2026
8-K Current report
Shareholder vote results
May 4, 2026 Apr 30, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
8-K Current report
Material agreement, New debt
Mar 23, 2026 Mar 23, 2026
3 Initial insider ownership Mar 20, 2026 Mar 20, 2026
ARS Annual report to shareholders Mar 12, 2026 Dec 31, 2025
DEFA14A Additional proxy material Mar 12, 2026 —
DEF 14A Proxy statement Mar 12, 2026 Apr 30, 2026
8-K Current report
Regulation FD disclosure
Feb 27, 2026 Feb 27, 2026
4 Insider transaction Feb 17, 2026 Feb 15, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 7, 2026
10-K Annual report Feb 3, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 2, 2026 Feb 2, 2026
4 Insider transaction Jan 30, 2026 Jan 28, 2026
4 Insider transaction Jan 30, 2026 Jan 28, 2026
4 Insider transaction Jan 30, 2026 Jan 28, 2026
4 Insider transaction Jan 30, 2026 Jan 28, 2026
4 Insider transaction Jan 30, 2026 Jan 28, 2026
4 Insider transaction Jan 30, 2026 Jan 28, 2026
4 Insider transaction Jan 30, 2026 Jan 28, 2026
4 Insider transaction Jan 30, 2026 Jan 28, 2026
4 Insider transaction Dec 2, 2025 Nov 28, 2025
4 Insider transaction Dec 2, 2025 Nov 28, 2025
4 Insider transaction Dec 2, 2025 Nov 28, 2025
4 Insider transaction Dec 2, 2025 Nov 28, 2025
4 Insider transaction Dec 2, 2025 Nov 28, 2025
4 Insider transaction Dec 2, 2025 Nov 28, 2025
4 Insider transaction Dec 2, 2025 Nov 28, 2025
10-Q Quarterly report Oct 24, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Oct 23, 2025 Oct 23, 2025
8-K Current report
Other events
Aug 14, 2025 Aug 14, 2025
424B5 Prospectus supplement Aug 7, 2025 —
8-K Current report
Other events
Aug 6, 2025 Aug 5, 2025
4 Insider transaction Aug 6, 2025 Aug 6, 2025
FWP Free writing prospectus Aug 5, 2025 —
424B5 Prospectus supplement Aug 5, 2025 —
8-K Current report
Other events
Aug 5, 2025 Aug 5, 2025
4 Insider transaction Aug 4, 2025 Aug 4, 2025
4 Insider transaction Jul 31, 2025 Jul 31, 2025
4 Insider transaction Jul 30, 2025 Jul 28, 2025
4 Insider transaction Jul 29, 2025 Jul 28, 2025
10-Q Quarterly report Jul 25, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Jul 24, 2025 Jul 24, 2025
144 Notice of proposed sale Jul 1, 2025 —
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction May 28, 2025 May 28, 2025
8-K Current report
Regulation FD disclosure
May 12, 2025 May 12, 2025
4 Insider transaction May 12, 2025 May 9, 2025
4 Insider transaction May 12, 2025 May 9, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 28, 2025 Apr 28, 2025
4 Insider transaction Apr 28, 2025 Apr 28, 2025
4 Insider transaction Apr 28, 2025 Apr 28, 2025
4 Insider transaction Apr 28, 2025 Apr 28, 2025
4 Insider transaction Apr 28, 2025 Apr 28, 2025
S-8 Employee stock plan registration Apr 28, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Apr 28, 2025 Apr 24, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 28, 2025 —
10-Q Quarterly report Apr 25, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Apr 24, 2025 Apr 24, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 24, 2025 Apr 24, 2025
4 Insider transaction Apr 7, 2025 Apr 3, 2025
8-K Current report
Officer or director change
Apr 7, 2025 Apr 2, 2025
ARS Annual report to shareholders Mar 12, 2025 Dec 31, 2024
DEFA14A Additional proxy material Mar 12, 2025 —
DEF 14A Proxy statement Mar 12, 2025 Apr 24, 2025
3 Initial insider ownership Mar 3, 2025 Mar 1, 2025
3 Initial insider ownership Mar 3, 2025 Mar 1, 2025
8-K Current report
Regulation FD disclosure
Feb 26, 2025 Feb 26, 2025
4 Insider transaction Feb 18, 2025 Feb 15, 2025
8-K Current report
Other events
Feb 14, 2025 Feb 14, 2025
4 Insider transaction Feb 12, 2025 Feb 10, 2025
4 Insider transaction Feb 12, 2025 Feb 10, 2025
4 Insider transaction Feb 10, 2025 Feb 7, 2025
424B5 Prospectus supplement Feb 7, 2025 —
424B5 Prospectus supplement Feb 6, 2025 —
8-K Current report
Other events
Feb 6, 2025 Feb 5, 2025
FWP Free writing prospectus Feb 5, 2025 —
424B5 Prospectus supplement Feb 5, 2025 —
POSASR Filing Feb 5, 2025 —
10-K Annual report Feb 4, 2025 Dec 31, 2024
4 Insider transaction Feb 3, 2025 Jan 30, 2025
4 Insider transaction Feb 3, 2025 Jan 30, 2025
4 Insider transaction Feb 3, 2025 Jan 30, 2025
4 Insider transaction Feb 3, 2025 Jan 30, 2025
4 Insider transaction Feb 3, 2025 Jan 30, 2025
4 Insider transaction Feb 3, 2025 Jan 30, 2025
4 Insider transaction Feb 3, 2025 Jan 30, 2025
4 Insider transaction Feb 3, 2025 Jan 30, 2025
4 Insider transaction Feb 3, 2025 Jan 30, 2025
8-K Current report
Officer or director change
Feb 3, 2025 Jan 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 3, 2025 Feb 3, 2025
4 Insider transaction Dec 12, 2024 Dec 11, 2024
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Dec 9, 2024 Dec 9, 2024
8-K Current report
Regulation FD disclosure
Nov 18, 2024 Nov 18, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
8-K Current report
Regulation FD disclosure
Nov 4, 2024 Nov 4, 2024
10-Q Quarterly report Oct 25, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Oct 24, 2024 Oct 24, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 23, 2024 —
4 Insider transaction Sep 4, 2024 Sep 4, 2024
10-Q Quarterly report Jul 26, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Jul 25, 2024 Jul 25, 2024
8-K/A Amended current report May 13, 2024 Mar 1, 2024
424B5 Prospectus supplement May 3, 2024 —
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 3, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
144 Notice of proposed sale Apr 29, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
Apr 26, 2024 Apr 25, 2024
10-Q Quarterly report Apr 26, 2024 Mar 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Apr 25, 2024 Apr 25, 2024
8-K Current report
Other events
Mar 14, 2024 Mar 14, 2024
424B7 Filing Mar 14, 2024 —
ARS Annual report to shareholders Mar 13, 2024 Dec 31, 2023
DEFA14A Additional proxy material Mar 13, 2024 —
DEF 14A Proxy statement Mar 13, 2024 Apr 25, 2024
8-K Current report
Material agreement
Mar 11, 2024 Mar 11, 2024
424B2 Prospectus Mar 11, 2024 —
4 Insider transaction Mar 4, 2024 Mar 4, 2024
3 Initial insider ownership Mar 4, 2024 Mar 1, 2024
3 Initial insider ownership Mar 4, 2024 Mar 1, 2024
3 Initial insider ownership Mar 4, 2024 Mar 1, 2024
3 Initial insider ownership Mar 4, 2024 Mar 1, 2024
3 Initial insider ownership Mar 4, 2024 Mar 1, 2024
8-K Current report
Regulation FD disclosure
Mar 1, 2024 Mar 1, 2024
8-K Current report
Material agreement, Acquisition or sale of assets, New debt, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
Mar 1, 2024 Feb 28, 2024
8-K Current report
Other events
Feb 27, 2024 Feb 26, 2024
8-K Current report
Other events
Feb 22, 2024 Feb 22, 2024
8-K Current report
Shareholder vote results, Regulation FD disclosure, Other events
Feb 21, 2024 Feb 21, 2024
4 Insider transaction Feb 15, 2024 Feb 15, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
4 Insider transaction Feb 13, 2024 Feb 10, 2024
4 Insider transaction Feb 13, 2024 Feb 12, 2024
4 Insider transaction Feb 13, 2024 Feb 10, 2024
8-K Current report
Other events
Feb 12, 2024 Feb 12, 2024
424B5 Prospectus supplement Feb 12, 2024 —
424B2 Prospectus Feb 12, 2024 —
424B2 Prospectus Feb 12, 2024 —
424B2 Prospectus Feb 12, 2024 —
8-K Current report
Other events
Feb 12, 2024 Feb 12, 2024
424B2 Prospectus Feb 12, 2024 —
424B7 Filing Feb 12, 2024 —
424B3 Prospectus Feb 12, 2024 —
424B2 Prospectus Feb 12, 2024 —
424B7 Filing Feb 12, 2024 —
424B7 Filing Feb 12, 2024 —
424B3 Prospectus Feb 12, 2024 —
424B2 Prospectus Feb 12, 2024 —
10-K Annual report Feb 9, 2024 Dec 31, 2023
S-3ASR Automatic shelf registration Feb 8, 2024 —
425 Filing Feb 8, 2024 —
8-K Current report
Results of operations, Regulation FD disclosure
Feb 8, 2024 Feb 8, 2024
425 Filing Feb 8, 2024 —
425 Filing Feb 7, 2024 —
8-K Current report
Other events
Feb 7, 2024 Feb 7, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Real Estate Investment Trusts (SIC 6798)
Listed as
DOC (NYSE)
Fiscal year ends
December 31
Incorporated in
MD
Headquarters
Denver, CO
SEC filer status
Large accelerated filer
SEC CIK
765880
Former names
HCP, INC. (until Oct 1, 2019); HEALTH CARE PROPERTY INVESTORS INC (until Sep 10, 2007)

Other Real Estate Investment Trusts companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.